<DOC>
	<DOCNO>NCT00576810</DOCNO>
	<brief_summary>The objective ot study compare efficacy safety 4 week treatment sodium picosulphate drop 10mg placebo patient functional constipation . In addition effect treatment quality life general health status evaluate</brief_summary>
	<brief_title>Sodium Picosulphate v . Placebo Functional Constipation</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Picosulfate sodium</mesh_term>
	<criteria>1 . Male female patient , age 18 2 . Suffering functional constipation , accord medical history , define Rome III diagnostic criterion Criteria fulfil last 3 month symptom onset least 6 month prior diagnosis . 1 . Must include 2 follow : strain least 25 % defecation lumpy hard stool least 25 % defecation sensation incomplete evacuation least 25 % defecation sensation anorectal obstruction/blockade least 25 % defecation manual manoeuvre facilitate least 25 % defecation ( e.g . digital evacuation , support pelvic floor ) few 3 defecation per week 2 . Loose stool rarely present without use laxatives 3 . There insufficient criterion irritable bowel syndrome ( IBS ) ( i.e . recurrent abdominal pain discomfort predominant symptom associate defecation change bowel habit , feature disorder defecation ) 3 . Able willing complete daily ediary 4 . Able willing use trial rescue medication ( i.e . 10 mg bisacodyl suppository ) 5 . Signed date write informed consent prior enrolment study accordance GCP local legislation 1 . Eating disorder anorexia nervosa bulimia , cause excessive use laxatives 2 . Patients whose constipation cause primary organic disease colon pelvic floor 3 . Patients metabolic disorder , neurological disorder , severe psychiatric disorder , significant disease intercurrent illness ( e.g . abdominal/gastrointestinal surgery ) , Investigators opinion , would interfere participation trial 4 . Patients restricted mobility ( e.g . wheelchair bound , bedridden ) , Investigators opinion , would interfere participation trial 5 . Patients know hypersensitivity sodium picosulphate , bisacodyl ingredient study medication ( sodium picosulphate match placebo drop , bisacodyl suppository ) 6 . Patients ileus , intestinal obstruction , acute surgical abdominal condition ( acute appendicitis acute inflammatory bowel disease ) , severe dehydration 7 . Patients anal fissure ulcerative proctitis mucosal damage 8 . Patients know clinically significant abnormal electrolyte value 9 . Patients whose concomitant therapy include opioid medication ( e.g . morphine , codeine ) 10 . Constipation , Investigators opinion , cause medication ( e.g . anticholinergic ) 11 . Patients willing discontinue use prohibit concomitant therapy ( see Section 4.2.2 ) 12 . Premenopausal woman ( last menstruation Â£ 1 year prior sign informed consent ) : nursing ( breastfeed ) pregnant OR childbearing potential practicing acceptable method birth control , plan continue use method throughout study . 13 . Participating another trial investigational product 1 month enrolment study 14 . Drug alcohol abuse 15 . Concomitant use antibiotic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>